Analyst Ratings for Tandem Diabetes Care (TNDM)
TNDM Rating Summary
TNDM Price Target Summary
- Highest: $55.00 (Barclays)
- Lowest: $14.00 (Nephron)
- Average: $27.55
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
=
Avg. $ Target:
$27.55 (+60.9%)
* Over Last 12-Mos
Rating Score: 5.6 / 10
Percentile Rank: 59%
Rating Score: 5.6 / 10
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 6/23/2026 | Deutsche Bank | N/A | New Coverage | Hold (N/A) |
15.50 (N/A) |
14.34 (17.12) |
19.39% | Details |
| 6/1/2026 | Wells Fargo | Lawrence Biegelsen | Upgrade | Overweight (Equal Weight) |
27.00 (21.00) |
16.72 (17.12) |
2.39% | Details |
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||


